(19)
(11) EP 3 707 149 A1

(12)

(43) Date of publication:
16.09.2020 Bulletin 2020/38

(21) Application number: 18874558.2

(22) Date of filing: 11.05.2018
(51) International Patent Classification (IPC): 
C07H 5/00(2006.01)
C07H 5/08(2006.01)
(86) International application number:
PCT/US2018/032321
(87) International publication number:
WO 2019/089080 (09.05.2019 Gazette 2019/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 31.10.2017 US 201762579343 P

(71) Applicant: Galectin Sciences, LLC
Norcross, GA 30071 (US)

(72) Inventors:
  • TRABER, Peter G.
    Alpharetta, Georgia 30022 (US)
  • ZOMER, Eliezer
    Newton, Massachusetts 02458 (US)
  • SLATE, Deirdre
    Berlin, Massachusetts 01503 (US)
  • JOHNSON, Joseph M.
    Arlington, Massachusetts 02474 (US)
  • GEORGE, Ryan
    Framingham, Massachusetts 01702 (US)
  • SHECHTER, Sharon
    Andover, Massachusetts 01810 (US)
  • NIR, Raphael
    Needham, Massachusetts 02492 (US)

(74) Representative: CMS Cameron McKenna Nabarro Olswang LLP 
Cannon Place 78 Cannon Street
London EC4N 6AF
London EC4N 6AF (GB)

   


(54) SELENOGALACTOSIDE COMPOUNDS FOR THE TREATMENT OF SYSTEMIC INSULIN RESISTANCE DISORDERS AND THE USE THEREOF